← Leaderboards
Azizul Haque
Ralph H Johnson Va Medical Center
$1,697,171
Attributed
$1,902,733
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $411.1K · FY2009–25$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,902,733 · 2
VA$0 · 2
By mechanism
R01$1,491,608 · 1
R21$411,125 · 1
I01$0 · 2
Top collaborators
- Naren L Banik6 shared
Others in their field
Top investigators on “Cd4 Positive T Lymphocytes”
- Barton F Haynes · Duke University$185,201,094
- James Dennis Neaton · Northwestern University$75,155,718
- Sharon A Nachman · Johns Hopkins University$74,725,055
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$62,274,832
- Dennis R. Burton · Scripps Research Institute$60,411,078
- Rama Rao Amara · Emory University$55,598,235
Research focus
Cd4 Positive T LymphocytesT-LymphocyteCellsCd8b1 GeneProteinsProductionAffectSamplingKnock-DownAntigen PresentationPlayFlow CytometryIn VitroMediatingLeukemia/LymphomaMaintenanceCytotoxic T-LymphocytesMalignant Lymphoid NeoplasmB-Cell NeoplasmImmune ResponseB-Cell LymphomasCd8-Positive T-LymphocytesImmuneImmunologic Surveillance
Grant awards (14)
A Novel Mechanism of Immune Escape by B-cell Lymphoma$0
I01 · FY2025 · VA · contact PI
A Novel Mechanism of Immune Escape by B-cell Lymphoma$0
I01 · FY2024 · VA · contact PI
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2023 · VA
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2022 · VA
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2021 · VA
Calpain cleavage of α-synuclein and T-cell reactivity in Parkinsonâs disease$411,125
R21 · FY2020 · NS · contact PI
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2020 · VA
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2019 · VA
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas$279,069
R01 · FY2013 · CA · contact PI
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas$296,881
R01 · FY2012 · CA · contact PI
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas$296,881
R01 · FY2011 · CA · contact PI
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas$303,106
R01 · FY2010 · CA · contact PI
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas$300,543
R01 · FY2009 · CA · contact PI
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas$15,128
R01 · FY2009 · CA · contact PI